Reference no: EM133032436

Project - Study Presentation

Introduction

In Part 4 of the Team Project, you will continue to use the Phase II, Randomized, Double-Blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of TJ301 (FE 999301) Administered Intravenously in Patients with Active Ulcerative Colitis protocol.We will take the final step of a clinical research study - Study Presentation. In addition, we will incorporate the fictional study data from Part 3 of the Team Project.

Instructions
The group presentation will be the opportunity to present your study, share the data collected on your ten patients, and share your understanding of the team study.

The PowerPoint presentation should include:

1. Title Slide - include the title of the protocol and the team members

2. Slide 2 - Points being presented in the presentation

3. Slide 3 - List the purpose of the trial

4. Side 4 - Inclusion/Exclusion criteria

5. Slide 5 - Patient population table summarizing data (from Data Collection assignment). Include:
a. Median age
b. Percent of males
c. Percent of patients that signed the Informed Consent
Slide 6 - Questions slide with contact information
Slide 7 - Reference Slide

Format

Your presentation should be in the following format:

1. Develop a seven-slide presentation (including a title slide and reference slide)

2. Choose a professional background

3. Use two relevant images to illustrate the concepts

4. Include one table and correlated graph

5. Write in a professional manner with a logical sequence

6. Use proper grammar and spelling

Attachment:- Part - Study Presentation.rar